RESUMO
Despite well-established treatment regimens, tuberculosis (TB) remains a public health burden; it disproportionately affects poor and marginalized populations who may not have access to social support, including migrants, homeless people and those dependent on drugs or alcohol. There is a clearly demonstrated need for housing and other appropriate social support, as part of a package of integrated clinical and social care. However, TB prevention and control efforts in the UK often do not address the specific vulnerabilities of these groups and it can be a challenge to support the continued TB treatment of these underserved populations. This challenge is exacerbated by complex issues concerning funding, immigration and the law. In this paper, we have reviewed current UK guidance and legislation, discussed several case studies and highlighted examples of existing models of community support for TB patients. Finally, we lay out our recommendations for ensuring a co-ordinated, whole system approach to successful TB treatment.
Assuntos
Emigração e Imigração , Pessoas Mal Alojadas , Tuberculose , Populações Vulneráveis , Adulto , Antituberculosos/economia , Antituberculosos/uso terapêutico , Farmacorresistência Bacteriana Múltipla , Feminino , Habitação , Humanos , Masculino , Pessoa de Meia-Idade , Saúde Pública , Apoio Social , Medicina Estatal/legislação & jurisprudência , Tuberculose/tratamento farmacológico , Tuberculose/economia , Tuberculose/prevenção & controle , Tuberculose/transmissão , Reino UnidoRESUMO
Se ha optimizado, desde el punto de vista funcional, un embutido cocido, útil para prevenir la aterosclerosis, usando aceites vegetales con alto contenido en ácidos grasos poliinsaturados.El producto obtenido a nivel artesanal y posteriormente a nivel industrial con el apoyo de importante frigorífico, no posee grasas animales adicionadas, no contiene ácidos grasos trans, tiene bajo contenido en sodio, es bajo en calorías, no presenta cambios organolépticos considerables con relación a productos similares de primeras marcas, y esta enriquecido con AGPIw3 obteniéndose una relación w6:w3 ideal.
Assuntos
Gorduras Insaturadas , Ácidos Graxos , Alimento Funcional , Óleos de PlantasRESUMO
BACKGROUND AND OBJECTIVES: Serological evaluation of maternal sera for platelet antibodies in suspected fetal/neonatal alloimmune thrombocytopenia (FNAITP) discloses in only approximately 30% of individuals a platelet-specific antibody. Transfusion-induced alloimmunization against human platelet antigen-15 (HPA-15) has been reported to be about as common as against HPA-5, the second most common platelet antibody. Thus, anti-HPA-15 may also contribute significantly to yet-unclear cases of FNAITP. MATERIALS AND METHODS: In this retrospective analysis, we provide data on maternal platelet antibodies from 309 mothers who delivered an offspring with suspected FNAITP. RESULTS: Genotyping maternal and paternal samples (together n = 573) revealed a gene frequency of 0.496 for HPA-15a and a gene frequency of 0.504 for HPA-15b. HPA-15 antibodies were detected in 2% of all samples. Anti-HPA-15a and -15b were detected in two and three samples, respectively. One serum reacted equally with HPA-15a and -15b platelets. The most frequent platelet-specific antibodies were anti-HPA-1a (22%), but anti-HPA-5b (8.4%) were more frequent than anti-HPA-15. In addition, panreactive (5.5%) or autoreactive (5.2%) anti-GPIIb/IIIa or anti-GPIb/IX were detectable in maternal samples. CONCLUSIONS: These data indicate that HPA-15 alloimmunization needs only to be considered in subjects with suspected FNAITP if no other platelet-specific antibody is detectable. The presence of panreactive or autoreactive antibodies should also be considered in neonatal thrombocytopenia.